Jackson Wilkinson is a Venture and Operating Partner with F-Prime, based in the Cambridge office. Jackson supports and advises early-stage healthcare and technology portfolio companies, getting hands-on to help accelerate early product, design, and engineering efforts.
Jackson has led product development at a variety of software companies. Most recently, he was Chief Technology Officer of Project Beacon COVID-19, rapidly expanding access to testing during the pandemic. Previously, he was Senior Vice President at PathAI and led product, design, and engineering, helping grow the company and its technology platform from seed stage through its Series B. Jackson was co-founder and CTO of Kinsights, and following its acquisition, led product and design as part of the management team at Care.com. Prior to his work in digital health and health tech, Jackson led design and UX efforts at consumer technology companies including Posterous (acquired by Twitter) and LinkedIn.
Jackson is a graduate of Bowdoin College, where he holds a degree cum laude in Music and Philosophy.
MediTrust Health is a provider of payment services for medical healthcare. The company is dedicated to helping patients solve their own medical payment problems through financial insurance, manage medical expenses more efficiently, and providing value to patients around medical finance, curative effect insurance, and drug benefits, helping patients manage their medical expenses.
The company specializes in personalized full-cycle cancer treatments and management, from prevention and early test of symptoms to the adoption of advanced cancer treatment methods.
Patina is reinventing primary care for older adults and those who care for them, so everyone gets the healthcare and aging experience they deserve.
NOCD is the #1 telehealth provider for the treatment of obsessive-compulsive disorder (OCD) and the leading Community-Driven Therapy company. The company helps people reclaim their lives with clinically proven OCD treatment by removing barriers to care, and by reducing the stigma associated with OCD. Inside the NOCD platform, members can quickly access a national network of licensed therapists that specialize in Exposure and Response Prevention (ERP), the “gold standard” for OCD treatment.
Gyenno is a digital health company based in Shenzhen, China that is developing a holistic specialty care platform to improve diagnosis, disease management, and clinical research in Parkinson’s Disease and other CNS disorders.
Castor is a leading provider of decentralized and hybrid clinical trial solutions. With the highest rated eClinical platform for decentralized and hybrid clinical trials, Castor’s plug and play platform offers rapid deployment at scale, enabling researchers to create a trial in a matter of clicks, with easy enrollment, consent and real-world data capture.
Erica Lee is a Senior Associate at F-Prime, focusing on investments in healthcare technology and services companies. Prior to joining F-Prime, she was an investment banking associate at Bank of America Merrill Lynch, where she advised on IPO and M&A transactions across the healthcare IT space.
Erica holds a B.A. from Georgetown University, where she majored in Finance and International Business.
Creating the industry’s first shared development platform backed by a shared data record, Zus aims to bring about a better health data reality by empowering a wave of new, digital-first healthcare builders who will create digital health technologies and services that are cheaper, more customizable, and more personalized. This vision drives Zus to proactively connect the largest array of traditional medical providers to novel health data sources so that health data becomes frictionless to use.
KnowYourself is a digital health company that is focused on promoting mental wellness in China.